These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Pharmacogenetics and human genetic polymorphisms. Daly AK Biochem J; 2010 Aug; 429(3):435-49. PubMed ID: 20626352 [TBL] [Abstract][Full Text] [Related]
47. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing. Lauschke VM; Ingelman-Sundberg M Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656 [TBL] [Abstract][Full Text] [Related]
48. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Lynch T; Price A Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140 [TBL] [Abstract][Full Text] [Related]
49. Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Hu L; Zhuo W; He YJ; Zhou HH; Fan L Pharmacogenet Genomics; 2012 Nov; 22(11):812-9. PubMed ID: 23047293 [TBL] [Abstract][Full Text] [Related]
50. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future. Alfirevic A; Pirmohamed M Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129 [TBL] [Abstract][Full Text] [Related]
51. Arylamine N-acetyltransferases and drug response. Meisel P Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143 [TBL] [Abstract][Full Text] [Related]
52. [Drug-Drug Interactions with Consideration of Pharmacogenetics]. Ozawa S Yakugaku Zasshi; 2018; 138(3):365-371. PubMed ID: 29503430 [TBL] [Abstract][Full Text] [Related]
53. Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents. Iemmolo R; La Cognata V; Morello G; Guarnaccia M; Arbitrio M; Alessi E; Cavallaro S Biosensors (Basel); 2020 Dec; 10(12):. PubMed ID: 33317085 [TBL] [Abstract][Full Text] [Related]
54. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics. Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468 [TBL] [Abstract][Full Text] [Related]
55. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs. Zhang Z; Wu Y; Tan NC; Jiang Y Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464 [TBL] [Abstract][Full Text] [Related]
56. Pharmacogenetics of cancer drugs. Hertz DL; Rae J Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932 [TBL] [Abstract][Full Text] [Related]
57. Strategies for Avoiding Benzopyrone Hepatotoxicity in Lymphedema Management-The Role of Pharmacogenetics, Metabolic Enzyme Gene Identification, and Patient Selection. Hu M; Piller NB Lymphat Res Biol; 2017 Dec; 15(4):317-323. PubMed ID: 29087786 [TBL] [Abstract][Full Text] [Related]
58. Pharmacogenetics of idiosyncratic adverse drug reactions. Pirmohamed M Handb Exp Pharmacol; 2010; (196):477-91. PubMed ID: 20020273 [TBL] [Abstract][Full Text] [Related]
59. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Johnson JA; Lima JJ Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951 [TBL] [Abstract][Full Text] [Related]
60. Measuring pharmacogenetics in special groups: geriatrics. Seripa D; Panza F; Daragjati J; Paroni G; Pilotto A Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1073-88. PubMed ID: 25990744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]